Duncan Gregory Scott
- SEC CIK
- 0001831127
No open-market purchases or sales filed in the past year.
Current role at each company
- DWTX Dogwood Therapeutics, Inc.CHIEF EXECUTIVE OFFICERas of Mar 6, 2026
- CRMD CorMedix Inc.Directoras of Jan 27, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Duncan Gregory Scott as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
DWTX Dogwood Therapeutics, Inc.
CHIEF EXECUTIVE OFFICER3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 18, 2023 (view filing) | Aug 17 | 1 day | Duncan Gregory ScottCHIEF EXECUTIVE OFFICER | PPurchase | +25.0K | $1.25 | +$31.3K | +77.0%57.5K after | |
| May 24, 2022 (view filing) | May 23 | 1 day | Duncan Gregory ScottCHIEF EXECUTIVE OFFICER | PPurchase | +7.50K | $4.52 | +$33.9K | +30.0%32.5K after | |
| Dec 22, 2021 (view filing) | Dec 21 | 1 day | Duncan Gregory ScottCHIEF EXECUTIVE OFFICER | PPurchase | +5.00K | $5.52 | +$27.6K | +25.0%25.0K after |